Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo
Authors:
- 1 August 2000
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 279 (2) , H459-H465
Abstract
We tested the hypothesis that nitric oxide (NO) inhibits endothelium-derived hyperpolarizing factor (EDHF)-induced vasodilation via a negative feedback pathway in the coronary microcirculation. Coronary microvascular diameters were measured using stroboscopic fluorescence microangiography. Bradykinin (BK)-induced dilation was mediated by EDHF, when NO and prostaglandin syntheses were inhibited, or by NO when EDHF and prostaglandin syntheses were blocked. Specifically, BK (20, 50, and 100 ng · kg−1· min−1ic) caused dose-dependent vasodilation similarly before and after administration of NG-monomethyl-l-arginine (l-NMMA) (3 μmol/min ic for 10 min) and indomethacin (Indo, 10 mg/kg iv). The residual dilation to BK withl-NMMA and Indo was completely abolished by suffusion of miconazole or an isosmotic buffer containing high KCl (60 mM), suggesting that this arteriolar vasodilation is mediated by the cytochrome P-450 derivative EDHF. BK-induced dilation was reduced by 39% after inhibition of EDHF and prostaglandin synthesis, and dilation was further inhibited by combined blockade withl-NMMA to a 74% reduction in the response. This suggests an involvement for NO in the vasodilation. After dilation to BK was assessed with l-NMMA and Indo, sodium nitroprusside (SNP, 1–3 μg · kg−1· min−1ic), an exogenous NO donor, was administered in a dose to increase the diameter to the original control value. Dilation to BK was virtually abolished when administered concomitantly with SNP duringl-NMMA and Indo ( P < 0.01 vs. before SNP), suggesting that NO inhibits EDHF-induced dilation. SNP did not affect adenosine- or papaverine-induced arteriolar dilation in the presence ofl-NMMA and Indo, demonstrating that the effect of SNP was not nonspecific. In conclusion, our data are the first in vivo evidence to suggest that NO inhibits the production and/or action of EDHF in the coronary microcirculation.Keywords
This publication has 31 references indexed in Scilit:
- Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium‐dependent relaxation to bradykinin in human small resistance‐like coronary arteriesBritish Journal of Pharmacology, 1997
- Endothelial dysfunction: Clinical implicationsProgress in Cardiovascular Diseases, 1997
- Identification of Epoxyeicosatrienoic Acids as Endothelium-Derived Hyperpolarizing FactorsCirculation Research, 1996
- Endothelium-Dependent HyperpolarizationCirculation, 1995
- Nitric oxide and its role in the cardiovascular systemProgress in Cardiovascular Diseases, 1995
- Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs.Circulation, 1994
- Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries.Journal of Clinical Investigation, 1993
- Increased vascular responsiveness to bradykinin in kidneys of spontaneously hypertensive rats. Effect of N omega-nitro-L-arginine.Hypertension, 1991
- Endotoxin impairs the response of rat anococcygeus muscle to electrical field stimulatinEuropean Journal of Pharmacology, 1991
- Potentiation and suppression of mouse liver cytochrome P‐450 isozymes during the acute‐phase response induced by bacterial endotoxinEuropean Journal of Biochemistry, 1988